Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company’s hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Competitive Strengths:
Gujarat Kidney & Super Speciality Ltd.’s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| NET Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | |
| Amount in ₹ Crore | ||||
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 1.85 | 2.74 |
| P/E (x) | 61.62 | 41.59 |
The Company Gujarat Kidney IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Estimated Amount (₹ in Cr.) |
|---|---|---|
| 1 | Proposed acquisition of Parekhs Hospital at Ahmedabad. | 77.00 |
| 2 | Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. | 12.40 |
| 3 | Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | 30.10 |
| 4 | Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | 6.83 |
| 5 | Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | 1.20 |
| 6 | Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | |
| 7 | Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch | 10.78 |
| IPO Date | 22 to 24 Dec, 2025 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Price Band | ₹108 to ₹114 |
| Lot Size | 128 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,20,00,000 shares (agg. up to ₹250.80 Cr) |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda are the company promoters.
| Share Holding Pre Issue | 99.10% |
| Share Holding Post Issue | 71.45% |
Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.
Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on April 10, 2026 Property Share Investment Trust REIT PropShare Celestia is the third scheme launched by Property Share Investment Trust, India’s first SEBI-registered small and medium REIT.
Last Updated on April 9, 2026 Om Power Transmission Ltd. IPO Incorporated in June 2011, Om Power Transmission Limited is a power transmission infrastructure engineering, procurement, and construction (EPC) company
Last Updated on April 1, 2026 Safety Controls & Devices Ltd. IPO Incorporated in June 2015, Safety Controls and Devices Limited specialises in EPC (Engineering, Procurement, and Construction), focusing on
You can contribute as little as
100, 200, 500 & so…
every bit counts.
